7. Oxygen Biotherapeutics (OXBT)
Company Profile: Oxygen Biotherapeutics develops intravenous and topical medical products that deliver oxygen to tissues in the body. The company is currently focused on traumatic brain injury, wound healing, dermatologic indications and decompression sickness.Earnings Reporting Date: July 14 (confirmed) Current Share Price: $2.44 2011 Share Price Performance: 27% Analyst Ratings: There are currently no analysts following Oxygen Biotherapeutics. What To Watch For: Oxygen Biotherapeutics hasn't reported positive net income since the quarter ended April 30, 2010, although that can be typical for a development stage biomedical company. Shares of Oxygen have managed to stay positive even after a sharp drop last month following the company's announcement of a $4.6 million private placement. For more upside, investors should be on watch for management comments on the company's Dermacyte skin care products and additional distribution agreements.
6. Ossen Innovation (OSN) Company Profile: Ossen Innovation is a China-based manufacturer of an array of plain surface, rare earth and zinc coated pre-stressed steel materials. Earnings Reporting Date: July 15 (unconfirmed) Current Share Price: $3.19 2011 Share Price Performance: -32% Analyst Ratings: Ossen Innovation is followed only by Global Hunter Securities, which rates the stock as a "buy." What To Watch For: Ossen Chairman Liang Tang said he expects the company to grow revenue in 2011 to $138.5 million to $144.6 million, compared with $117.5 million in 2010. Investors should keep an eye on the company's margins as Tang has said he expects gross margins for coated products to increase to 25% to 30% from 23% due to a shortage of coated pre-stressed steel materials.